11-17578490-G-T
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_001292063.2(OTOG):c.2723G>T(p.Arg908Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0053 in 1,539,486 control chromosomes in the GnomAD database, including 25 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001292063.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTOG | NM_001292063.2 | c.2723G>T | p.Arg908Leu | missense_variant | 23/56 | ENST00000399397.6 | NP_001278992.1 | |
OTOG | NM_001277269.2 | c.2759G>T | p.Arg920Leu | missense_variant | 22/55 | NP_001264198.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OTOG | ENST00000399397.6 | c.2723G>T | p.Arg908Leu | missense_variant | 23/56 | 5 | NM_001292063.2 | ENSP00000382329.2 | ||
OTOG | ENST00000399391.7 | c.2759G>T | p.Arg920Leu | missense_variant | 22/55 | 5 | ENSP00000382323.2 | |||
OTOG | ENST00000342528.2 | n.227G>T | non_coding_transcript_exon_variant | 1/22 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00346 AC: 526AN: 152230Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.00339 AC: 472AN: 139106Hom.: 1 AF XY: 0.00336 AC XY: 254AN XY: 75642
GnomAD4 exome AF: 0.00550 AC: 7631AN: 1387138Hom.: 24 Cov.: 32 AF XY: 0.00539 AC XY: 3691AN XY: 684564
GnomAD4 genome AF: 0.00345 AC: 526AN: 152348Hom.: 1 Cov.: 33 AF XY: 0.00309 AC XY: 230AN XY: 74506
ClinVar
Submissions by phenotype
not provided Benign:4
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 24, 2019 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2024 | OTOG: BP4, BS2 - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Oct 23, 2015 | p.Arg920Leu in exon 22 of OTOG: This variant is not expected to have clinical si gnificance because it has been identified in 0.6 % (29/4534) of European chromos omes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs144060182). - |
OTOG-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 11, 2021 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at